Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-107608·CalciMedica, Inc.
Schedule 13G ownership disclosure
CALCIMEDICA INC
Common Stock, par value $0.0001 per share · CUSIP: 38942Q202
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Soleus Private Equity Fund III, L.P.
Shares: 537,928.00 · Class: 3.8%
- Soleus Private Equity GP III, LLC
Shares: 537,928.00 · Class: 3.8%
- Soleus PE GP III, LLC
Shares: 537,928.00 · Class: 3.8%
- Soleus Capital Master Fund, L.P.
Shares: 537,928.00 · Class: 3.8%
- Soleus Capital, LLC
Shares: 537,928.00 · Class: 3.8%
- Soleus Capital Group, LLC
Shares: 537,928.00 · Class: 3.8%
- Soleus Capital Management, L.P.
Shares: 1,075,856.00 · Class: 7.5%
- Soleus GP, LLC
Shares: 1,075,856.00 · Class: 7.5%
- Guy Levy
Shares: 1,075,856.00 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-107608
- Form type
- SCHEDULE 13G/A
- Filer
- CalciMedica, Inc.
- CIK
- CIK 1534133
- Filed
- Nov 07, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership